Parabilis Medicines, Inc. (PBLS) News
Follow Parabilis Medicines, Inc. (PBLS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Parabilis Chief Medical Officer to leave effective Sept. 30, 2026
Parabilis said Fawzi Benzaghou, M.D. will transition from his role as chief medical officer effective Sept. 30, 2026.
REGULATION | Sep 02, 2026, 08:13 PM UTC
L
Parabilis Medicines to participate in Morgan Stanley 24th healthcare conference
Parabilis Medicines says its Chairman and President will participate in the Morgan Stanley 24th Annual Global Healthcare Conference.
EQUITY | Sep 01, 2026, 11:08 AM UTC
L
Parabilis Medicines to participate in Morgan Stanley healthcare conference
Parabilis Medicines plans to participate in the Morgan Stanley 24th Annual Global Healthcare Conference.
EQUITY | Sep 01, 2026, 11:00 AM UTC
L
Parabilis Medicines appoints Dr. Craig L. Tendler to board
Parabilis Medicines (PBLS) appoints drug development leader Craig L. Tendler, M.D., to its board of directors.
EQUITY | Aug 25, 2026, 11:00 AM UTC
L
Parabilis Medicines reports Q2 2026 financial results, business updates
Parabilis Medicines (PBLS) reports its second-quarter 2026 financial results and provides accompanying business updates.
EARNINGS | Aug 13, 2026, 11:01 AM UTC
L
This Parabilis Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Evercore ISI Grou
EQUITY | Jul 06, 2026, 11:11 AM UTC
L
Buy Recommendation Issued On PBLS By Guggenheim
2026-07-06 03:15:02 ET Guggenheim analyst issues BUY recommendation for PBLS on July 6, 2026 06:39AM ET. <
EQUITY | Jul 06, 2026, 07:15 AM UTC